Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 2006, 56 (2): 106-130.
Article
PubMed
Google Scholar
McCawley LJ, Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol. 2001, 13 (5): 534-540. 10.1016/S0955-0674(00)00248-9.
Article
CAS
PubMed
Google Scholar
Pasco S, Ramont L, Maquart FX, Monboisse JC: Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol. 2004, 49 (3): 221-233.
Article
PubMed
Google Scholar
Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, Chou MC, Hsieh YS: Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta. 2006, 371 (1-2): 92-6. 10.1016/j.cca.2006.02.026.
Article
CAS
PubMed
Google Scholar
Islekel H, Oktay G, Terzi C, Canda AE, Fuzun M, Kupelioglu A: Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem Funct. 2006
Google Scholar
Zhao W, Liu H, Xu S, Entschladen F, Niggemann B, Zanker KS, Han R: Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett. 2001, 162 Suppl: S49-S55. 10.1016/S0304-3835(00)00656-X.
Article
CAS
PubMed
Google Scholar
Shellman YG, Makela M, Norris DA: Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res. 2006, 16 (3): 207-211. 10.1097/01.cmr.0000215033.92693.73.
Article
CAS
PubMed
Google Scholar
van den Oord JJ, Paemen L, Opdenakker G, de Wolf-Peeters C: Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol. 1997, 151 (3): 665-670.
CAS
PubMed
PubMed Central
Google Scholar
Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest Dermatol. 2000, 115 (3): 337-344. 10.1046/j.1523-1747.2000.00068.x.
Article
CAS
PubMed
Google Scholar
Corte MD, Gonzalez LO, Corte MG, Quintela I, Pidal I, Bongera M, Vizoso F: Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers. 2005, 20 (4): 242-248.
CAS
PubMed
Google Scholar
Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S: High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res. 2005, 11 (14): 5158-5166. 10.1158/1078-0432.CCR-04-2478.
Article
CAS
PubMed
Google Scholar
Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S: Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci. 1999, 878: 212-227. 10.1111/j.1749-6632.1999.tb07687.x.
Article
CAS
PubMed
Google Scholar
Jung K, Meisser A, Bischof P: Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes. Int J Cancer. 2005, 116 (6): 1000-1; author reply 1002-3. 10.1002/ijc.21129.
Article
CAS
PubMed
Google Scholar
Makowski GS, Ramsby ML: Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma. Anal Biochem. 2003, 322 (2): 283-286. 10.1016/j.ab.2003.07.030.
Article
CAS
PubMed
Google Scholar
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G: Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002, 37 (6): 375-536. 10.1080/10409230290771546.
Article
CAS
PubMed
Google Scholar
Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, Berwick M: Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 2006, 27 (3): 610-618. 10.1093/carcin/bgi252.
Article
CAS
PubMed
Google Scholar
dbSNP. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=snp]
Gough J, Karplus K, Hughey R, Chothia C: Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. Journal of molecular biology. 2001, 313 (4): 903-919. 10.1006/jmbi.2001.5080.
Article
CAS
PubMed
Google Scholar
Bennett CD, Campbell MN, Cook CJ, Eyre DJ, Nay LM, Nielsen DR, Rasmussen RP, Bernard PS: The LightTyper: high-throughput genotyping using fluorescent melting curve analysis. Biotechniques. 2003, 34 (6): 1288-92, 1294-5.
CAS
PubMed
Google Scholar
Ronaghi M: Pyrosequencing for SNP genotyping. Methods Mol Biol. 2003, 212: 189-195.
CAS
PubMed
Google Scholar
Franchina M, Kadin ME, Abraham LJ: Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders. Cancer Epidemiol Biomarkers Prev. 2005, 14 (5): 1322-1325. 10.1158/1055-9965.EPI-04-0826.
Article
CAS
PubMed
Google Scholar
Oefner PJ: Allelic discrimination by denaturing high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000, 739 (2): 345-355. 10.1016/S0378-4347(99)00571-X.
Article
CAS
PubMed
Google Scholar
Orlow I, Roy P, Barz A, Canchola R, Song Y, Berwick M: Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations. J Mol Diagn. 2001, 3 (4): 158-163.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics. 1997, 53 (4): 1253-1261. 10.2307/2533494.
Article
CAS
PubMed
Google Scholar
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481. 10.2307/2281868.
Article
Google Scholar
Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995, 12 (5): 921-927.
CAS
PubMed
Google Scholar
Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation tests for allelic associations. Hum Hered. 2000, 50 (2): 133-139. 10.1159/000022901.
Article
CAS
PubMed
Google Scholar
Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70 (2): 425-434. 10.1086/338688.
Article
PubMed
Google Scholar
PolyPhen. [http://genetics.bwh.harvard.edu/pph]
Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE: Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999, 30 (12): 2612-2616.
Article
CAS
PubMed
Google Scholar
Shimajiri S, Arima N, Tanimoto A, Murata Y, Hamada T, Wang KY, Sasaguri Y: Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 1999, 455 (1-2): 70-74. 10.1016/S0014-5793(99)00863-7.
Article
CAS
PubMed
Google Scholar
Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, Strauss JF: A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod. 2002, 8 (5): 494-501. 10.1093/molehr/8.5.494.
Article
CAS
PubMed
Google Scholar
Bodey B, Bodey B, Siegel SE, Kaiser HE: Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In Vivo. 2001, 15 (1): 57-64.
CAS
PubMed
Google Scholar
Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S: High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer. 2002, 97 (4): 432-438. 10.1002/ijc.1636.
Article
CAS
PubMed
Google Scholar
Hofmann UB, Eggert AA, Blass K, Brocker EB, Becker JC: Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res. 2003, 63 (23): 8221-8225.
CAS
PubMed
Google Scholar
Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999, 99 (14): 1788-1794.
Article
CAS
PubMed
Google Scholar
Grieu F, Li WQ, Iacopetta B: Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat. 2004, 88 (3): 197-204. 10.1007/s10549-004-0595-6.
Article
CAS
PubMed
Google Scholar
Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K, Yasui W: A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol. 2005, 131 (1): 19-25. 10.1007/s00432-004-0621-4.
Article
CAS
PubMed
Google Scholar
Chicoine E, Estève PO, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y: Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun. 2002, 297 (4): 765-772. 10.1016/S0006-291X(02)02283-0.
Article
CAS
PubMed
Google Scholar
Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M, Schneider SW: Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res. 2004, 64 (24): 8924-8931. 10.1158/0008-5472.CAN-04-0324.
Article
CAS
PubMed
Google Scholar
Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, Manabe T, Kamoto T, Habuchi T, Ogawa O: Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 2006
Google Scholar